Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT03170960 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT03170960

Sponsor

Exelixis

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-09-05

Primary completion

2023-02-21

Enrollment

914

View on ClinicalTrials.gov